Latest Publications

Share:

Recent 340B program developments

Legal challenges to the significant Medicare reimbursement cuts for drugs purchased by most hospitals under the 340B program continue. As previously reported, the Centers for Medicare & Medicaid Services (CMS) issued a final...more

EMTALA screening for behavioral health patients

With the increase in mental and behavioral health patients presenting to emergency departments, hospitals often struggle with how to adequately and efficiently serve this patient population while complying with the...more

Ohio Board of Pharmacy releases proposed rules on pain management and office-based opioid treatment clinics

The State of Ohio Board of Pharmacy recently issued a number of proposed rule sets for public comment. Notably included were new rules on the operation of office-based opioid treatment (OBOT) clinics and rules governing the...more

CMS imposes massive cuts on 340B program; Hospital associations’ legal challenge dismissed

On November 1, 2017, CMS issued a final rule that became effective January 1, 2018, under which hospitals serving a disproportionate share of low-income patients (DSH hospitals) will receive nearly 27 percent less in...more

Opioid prescribing and potential liability will impact providers in Ohio and across the nation in 2018

Over the last year, Ohio has enacted and implemented numerous prescribing restrictions on opioid drugs for the management of acute pain in response to the nationwide opioid crisis and the proliferation of prescription...more

5 Results
/
View per page
Page: of 1

"My best business intelligence,
in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.